BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18693165)

  • 1. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y; Kawachi Y; Furuta J; Otsuka F
    Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
    Ball NJ; Cowan BJ; Hashimoto SA
    J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed drug eruption with interferon-beta-1b.
    Tai YJ; Tam M
    Australas J Dermatol; 2005 Aug; 46(3):154-7. PubMed ID: 16008645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
    Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P
    Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis.
    Serarslan G; Okuyucu E; Melek I; Hakverdi S; Duman T
    Mult Scler; 2008 Mar; 14(2):259-61. PubMed ID: 18337427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon beta-1b and secondary progressive multiple sclerosis: licence extension. Useful, but further assessment required.
    Prescrire Int; 2000 Aug; 9(48):110-1. PubMed ID: 11067719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon beta-induced panniculitis mimicking acute appendicitis.
    Poulin F; Rico P; Côté J; Bégin LR
    Arch Dermatol; 2009 Aug; 145(8):916-7. PubMed ID: 19687423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of psoriasis in patients undergoing treatment with interferon-beta].
    Navne JE; Hedegaard U; Bygum A
    Ugeskr Laeger; 2005 Aug; 167(32):2903-4. PubMed ID: 16109199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.
    Baum K; O'Leary C; Coret Ferrer F; Klímová E; Procházková L; Bugge J;
    Mult Scler; 2007 Nov; 13(9):1153-60. PubMed ID: 17967843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon therapy of multiple sclerosis].
    Jensen D
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon beta-1A: new preparation. A short-term impact on the course of multiple sclerosis.
    Prescrire Int; 1998 Oct; 7(37):142-3. PubMed ID: 10915418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-beta1b in multiple sclerosis.
    Buttmann M; Rieckmann P
    Expert Rev Neurother; 2007 Mar; 7(3):227-39. PubMed ID: 17341170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
    Mazzon E; Guarneri C; Giacoppo S; Rifici C; Tchernev G; Polimeni G; Wollina U
    Int J Immunopathol Pharmacol; 2014; 27(4):669-74. PubMed ID: 25572749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermal fibrosis and cutaneous necrosis after recombinant interferon-beta1a injection in a multiple sclerosis patient.
    Ozden MG; Erel A; Erdem O; Oztas MO
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):112-3. PubMed ID: 15649205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent injection site reactions from interferon beta 1-b.
    Samuel L; Lowenstein EJ
    J Drugs Dermatol; 2006 Apr; 5(4):366-7. PubMed ID: 16673806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local reactions after subcutaneous injections of beta-interferon.
    van Rengen A; Goossens A
    Contact Dermatitis; 1998 Oct; 39(4):209. PubMed ID: 9817241
    [No Abstract]   [Full Text] [Related]  

  • 17. Local reactions associated with subcutaneous injections of both beta-interferon 1a and 1b.
    García-F-Villalta M; Daudén E; Sánchez J; Fraga J; Ramo C; García-Díez A
    Acta Derm Venereol; 2001 May; 81(2):152. PubMed ID: 11501663
    [No Abstract]   [Full Text] [Related]  

  • 18. Lupus erythematosus profundus (lupus panniculitis) induced by interferon-beta in a multiple sclerosis patient.
    Gono T; Matsuda M; Shimojima Y; Kaneko K; Murata H; Ikeda S
    J Clin Neurosci; 2007 Oct; 14(10):997-1000. PubMed ID: 17669654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis, interferon beta-1b and depression A prospective investigation.
    Feinstein A; O'Connor P; Feinstein K
    J Neurol; 2002 Jul; 249(7):815-20. PubMed ID: 12140662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous vasculitis associated with interferon beta-1b treatment for multiple sclerosis.
    Szilasiová J; Gdovinová Z; Jautová J; Baloghová J; Ficová M; Bohus P
    Clin Neuropharmacol; 2009; 32(5):301-3. PubMed ID: 19820436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.